the central pharmacy limited

3.5

the central pharmacy limited Company Information

Share THE CENTRAL PHARMACY LIMITED
Live 
MatureSmallDeclining

Company Number

SC185507

Registered Address

suite 2, ground floor, orchard brae house, edinburgh, EH4 2HS

Industry

Other business support service activities n.e.c.

 

Telephone

01259722851

Next Accounts Due

December 2024

Group Structure

View All

Directors

Rose Gray26 Years

Shareholders

communicare medical limited 100%

the central pharmacy limited Estimated Valuation

£1.5m

Pomanda estimates the enterprise value of THE CENTRAL PHARMACY LIMITED at £1.5m based on a Turnover of £2.5m and 0.59x industry multiple (adjusted for size and gross margin).

the central pharmacy limited Estimated Valuation

£481.9k

Pomanda estimates the enterprise value of THE CENTRAL PHARMACY LIMITED at £481.9k based on an EBITDA of £105.3k and a 4.58x industry multiple (adjusted for size and gross margin).

the central pharmacy limited Estimated Valuation

£1.3m

Pomanda estimates the enterprise value of THE CENTRAL PHARMACY LIMITED at £1.3m based on Net Assets of £512.9k and 2.54x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

The Central Pharmacy Limited Overview

The Central Pharmacy Limited is a live company located in edinburgh, EH4 2HS with a Companies House number of SC185507. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in April 1998, it's largest shareholder is communicare medical limited with a 100% stake. The Central Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £2.5m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

The Central Pharmacy Limited Health Check

Pomanda's financial health check has awarded The Central Pharmacy Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

1 Strong

positive_score

8 Regular

positive_score

3 Weak

size

Size

annual sales of £2.5m, make it in line with the average company (£3m)

£2.5m - The Central Pharmacy Limited

£3m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (4.1%)

-2% - The Central Pharmacy Limited

4.1% - Industry AVG

production

Production

with a gross margin of 38.5%, this company has a comparable cost of product (38.5%)

38.5% - The Central Pharmacy Limited

38.5% - Industry AVG

profitability

Profitability

an operating margin of 1% make it less profitable than the average company (6.5%)

1% - The Central Pharmacy Limited

6.5% - Industry AVG

employees

Employees

with 21 employees, this is similar to the industry average (20)

21 - The Central Pharmacy Limited

20 - Industry AVG

paystructure

Pay Structure

on an average salary of £43.5k, the company has an equivalent pay structure (£43.5k)

£43.5k - The Central Pharmacy Limited

£43.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £118.9k, this is equally as efficient (£137.2k)

£118.9k - The Central Pharmacy Limited

£137.2k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 41 days, this is near the average (40 days)

41 days - The Central Pharmacy Limited

40 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 80 days, this is slower than average (34 days)

80 days - The Central Pharmacy Limited

34 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 47 days, this is more than average (29 days)

47 days - The Central Pharmacy Limited

29 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 23 weeks, this is average cash available to meet short term requirements (28 weeks)

23 weeks - The Central Pharmacy Limited

28 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 62%, this is a similar level of debt than the average (60.4%)

62% - The Central Pharmacy Limited

60.4% - Industry AVG

THE CENTRAL PHARMACY LIMITED financials

EXPORTms excel logo

The Central Pharmacy Limited's latest turnover from March 2023 is estimated at £2.5 million and the company has net assets of £512.9 thousand. According to their latest financial statements, The Central Pharmacy Limited has 21 employees and maintains cash reserves of £228.2 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover2,496,6572,248,1862,299,1252,659,4572,340,1172,368,4862,078,6302,619,5943,527,8783,167,7074,299,0034,485,1274,437,1433,963,911
Other Income Or Grants00000000000000
Cost Of Sales1,535,7211,390,1401,441,8661,649,2211,457,0861,467,2321,263,8741,626,9142,233,0312,018,5312,722,3022,762,7102,663,9412,363,960
Gross Profit960,936858,046857,2581,010,236883,030901,254814,756992,6801,294,8471,149,1761,576,7011,722,4171,773,2021,599,951
Admin Expenses935,157834,424775,960838,264885,078859,381729,274860,9371,201,1401,305,3391,575,8681,680,0531,785,326889,521
Operating Profit25,77923,62281,298171,972-2,04841,87385,482131,74393,707-156,16383342,364-12,124710,430
Interest Payable44,37032,74228,55327,05832,05333,13633,99031,95026,95125,08329,94142,13054,10430,036
Interest Receivable10,9682,4493232291,2008064768024934376528831,047569
Pre-Tax Profit-7,623-6,67153,068145,143-32,9019,54351,968100,59567,249-180,809-28,4561,116-65,181680,964
Tax00-10,083-27,5770-1,813-10,393-20,119-14,12200-2900-190,670
Profit After Tax-7,623-6,67142,985117,566-32,9017,73041,57480,47653,127-180,809-28,456826-65,181490,294
Dividends Paid00000000000000
Retained Profit-7,623-6,67142,985117,566-32,9017,73041,57480,47653,127-180,809-28,456826-65,181490,294
Employee Costs913,662956,9241,000,000909,658919,932833,065780,375784,344996,438882,8621,216,6181,283,0971,299,4821,129,130
Number Of Employees2123252324232222282535373832
EBITDA*105,300102,826137,780233,55258,947102,563144,622190,457164,177-49,389140,573188,890139,404830,514

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets196,675232,514199,76199,072113,625126,373140,093147,020335,155362,329545,902600,795660,045640,391
Intangible Assets275,197317,536359,874402,212444,549486,887529,225571,563613,901656,2391,300,2271,384,0551,467,8881,551,716
Investments & Other00000000000000
Debtors (Due After 1 year)00000000000000
Total Fixed Assets471,872550,050559,635501,284558,174613,260669,318718,583949,0561,018,5681,846,1291,984,8502,127,9332,192,107
Stock & work in progress200,764178,013198,139228,139175,228171,187158,704153,121136,165127,421154,901147,753174,701163,789
Trade Debtors283,902235,799230,788274,190226,616266,831216,504305,578349,086321,244384,438453,950470,379469,658
Group Debtors00000000000000
Misc Debtors165,967164,452157,124162,618140,139142,278110,55536,870000000
Cash228,234287,894365,153280,770177,913141,975180,577200,012120,65476,61798,323162,321190,857227,763
misc current assets00000000000000
total current assets878,867866,158951,204945,717719,896722,271666,340695,581605,905525,282637,662764,024835,937861,210
total assets1,350,7391,416,2081,510,8391,447,0011,278,0701,335,5311,335,6581,414,1641,554,9611,543,8502,483,7912,748,8742,963,8703,053,317
Bank overdraft75,05158,36141,53034,85133,66233,66233,66632,510000000
Bank loan00000000000000
Trade Creditors 338,608337,905314,761425,022361,604340,803315,887400,510725,064628,097962,1451,011,1881,038,126863,065
Group/Directors Accounts19,49319,49354,49320,06320,62820,62820,62832,128000000
other short term finances00000000000000
hp & lease commitments00000000000000
other current liabilities71,58765,291102,73986,85267,91977,28874,97366,076000000
total current liabilities504,739481,050513,523566,788483,813472,381445,154531,224725,064628,097962,1451,011,1881,038,126863,065
loans327,304405,038465,216394,579424,066458,321493,926527,588422,968406,301365,492555,764740,551924,185
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities00000000137,126292,776743,532737,680746,235756,625
provisions5,7579,5584,8671,3863,5095,2464,7255,0730015,13718,30113,84319,146
total long term liabilities333,061414,596470,083395,965427,575463,567498,651532,661560,094699,0771,124,1611,311,7451,500,6291,699,956
total liabilities837,800895,646983,606962,753911,388935,948943,8051,063,8851,285,1581,327,1742,086,3062,322,9332,538,7552,563,021
net assets512,939520,562527,233484,248366,682399,583391,853350,279269,803216,676397,485425,941425,115490,296
total shareholders funds512,939520,562527,233484,248366,682399,583391,853350,279269,803216,676397,485425,941425,115490,296
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit25,77923,62281,298171,972-2,04841,87385,482131,74393,707-156,16383342,364-12,124710,430
Depreciation37,18236,86614,14419,24318,65718,35216,80216,37628,13243,69255,91262,69367,70057,424
Amortisation42,33942,33842,33842,33742,33842,33842,33842,33842,33863,08283,82883,83383,82862,660
Tax00-10,083-27,5770-1,813-10,393-20,119-14,12200-2900-190,670
Stock22,751-20,126-30,00052,9114,04112,4835,58316,9568,744-27,4807,148-26,94810,912163,789
Debtors49,61812,339-48,89670,053-42,35482,050-15,389-6,63827,842-63,194-69,512-16,429721469,658
Creditors70323,144-110,26163,41820,80124,916-84,623-324,55496,967-334,048-49,043-26,938175,061863,065
Accruals and Deferred Income6,296-37,44815,88718,933-9,3692,3158,89766,076000000
Deferred Taxes & Provisions-3,8014,6913,481-2,123-1,737521-3485,0730-15,137-3,1644,458-5,30319,146
Cash flow from operations36,129101,000115,700163,239106,95533,96967,961-93,385210,436-307,900150,730209,497297,529888,608
Investing Activities
capital expenditure-1,343-69,619-114,833-4,690-5,909-4,632-9,875171,759-958720,787-1,019-3,443-87,354-2,312,191
Change in Investments00000000000000
cash flow from investments-1,343-69,619-114,833-4,690-5,909-4,632-9,875171,759-958720,787-1,019-3,443-87,354-2,312,191
Financing Activities
Bank loans00000000000000
Group/Directors Accounts0-35,00034,430-56500-11,50032,128000000
Other Short Term Loans 00000000000000
Long term loans-77,734-60,17870,637-29,487-34,255-35,605-33,662104,62016,66740,809-190,272-184,787-183,634924,185
Hire Purchase and Lease Commitments00000000000000
other long term liabilities0000000-137,126-155,650-450,7565,852-8,555-10,390756,625
share issue00000000000002
interest-33,402-30,293-28,230-26,829-30,853-32,330-33,514-31,148-26,458-24,646-29,289-41,247-53,057-29,467
cash flow from financing-111,136-125,47176,837-56,881-65,108-67,935-78,676-31,526-165,441-434,593-213,709-234,589-247,0811,651,345
cash and cash equivalents
cash-59,660-77,25984,383102,85735,938-38,602-19,43579,35844,037-21,706-63,998-28,536-36,906227,763
overdraft16,69016,8316,6791,1890-41,15632,510000000
change in cash-76,350-94,09077,704101,66835,938-38,598-20,59146,84844,037-21,706-63,998-28,536-36,906227,763

the central pharmacy limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for the central pharmacy limited. Get real-time insights into the central pharmacy limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

The Central Pharmacy Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for the central pharmacy limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other small companies, companies in EH4 area or any other competitors across 12 key performance metrics.

the central pharmacy limited Ownership

THE CENTRAL PHARMACY LIMITED group structure

The Central Pharmacy Limited has no subsidiary companies.

Ultimate parent company

1 parent

THE CENTRAL PHARMACY LIMITED

SC185507

THE CENTRAL PHARMACY LIMITED Shareholders

communicare medical limited 100%

the central pharmacy limited directors

The Central Pharmacy Limited currently has 1 director, Ms Rose Gray serving since Apr 1998.

officercountryagestartendrole
Ms Rose GrayScotland67 years Apr 1998- Director

P&L

March 2023

turnover

2.5m

+11%

operating profit

25.8k

0%

gross margin

38.5%

+0.85%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

512.9k

-0.01%

total assets

1.4m

-0.05%

cash

228.2k

-0.21%

net assets

Total assets minus all liabilities

the central pharmacy limited company details

company number

SC185507

Type

Private limited with Share Capital

industry

82990 - Other business support service activities n.e.c.

incorporation date

April 1998

age

26

incorporated

UK

accounts

Total Exemption Full

ultimate parent company

previous names

N/A

last accounts submitted

March 2023

address

suite 2, ground floor, orchard brae house, edinburgh, EH4 2HS

accountant

WHITELAW WELLS

auditor

-

the central pharmacy limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 5 charges/mortgages relating to the central pharmacy limited. Currently there are 1 open charges and 4 have been satisfied in the past.

charges

the central pharmacy limited Companies House Filings - See Documents

datedescriptionview/download